Opioid prescribing has been highly scrutinized in the US over the last 10 yrs. Yet, patients continue to present to primary care with complaints of pain. Opioids remain a cornerstone of treatment. This session will focus on how and when it is appropriate to prescribe opioids in primary care. | 1.50 credits (1.50 Pharmacology) | $40

During the last 20 years, the rules and regulations regarding pain, opioid prescribing and opioid use disorder have changed significantly. Attendees will be taught the latest and most up-to-date information on DEA’s authority and background, licensing, registration, drug diversion, telemedicine, medication assistance treatment, nationwide opioid prescribing guidelines and case studies, along with learning risk mitigation strategies and best practices that will safeguard their practices. The instructor is a former DEA Special Agent with over 30 years of public service with real life prescription opioid experience. | 1.50 credits (1.00 Pharmacology) | $40

Nurse Practitioners receive limited formal pharmacology education in their primary training. Understanding the role that sodium and calcium channel blockers, anti-inflammatories and serotonin non-norepinephrine reuptake inhibitors can play in the management of chronic and acute pain, will provide confidence and skill to the care of patients with pain. This lecture will focus on safe and effective use of opioid and non-opioid analgesics for acute and chronic pain treatment. It will provide clinicians with the confidence and scientific education needed to effectively provide appropriate pharmaceutical therapies for the treatment of pain. | 1.50 credits (1.50 Pharmacology) | $40

Given the limited access to mental health specialists, primary care practitioners must often diagnose, initiate treatment, and chronically manage different anxiety disorders. This presentation utilizes evidence-based medicine and case studies to discuss the underlying pathophysiology of anxiety and the different options of pharmaceuticals in the treatment of anxiety. | 1.50 credits (1.50 Pharmacology) | $45

Chronic kidney disease is a common complication of type 2 diabetes. Over the last ten years, evidence has accumulated that some glucose lowering agents are more effective than others at retarding progression of CKD in the setting of type 2 diabetes. This session will review these pharmacologic strategies for retarding progression. | 1.50 credits (1.30 Pharmacology) | $40

This presentation discusses updated diagnostic criteria and psychometric approaches to improve case identification, diagnosis & treatment of attention deficit-hyperactivity disorders. ADHD is redefined in the context of epigenetics and neurobiology, with specific attention to contemporary pharmacological approaches to manage the symptoms. Practical applications for nurse practitioners are presented. | 1.0 credits (0.66 Pharmacology) | $30

Adolescent substance use has followed familiar trends for several decades with alcohol, nicotine, and cannabis leading other drugs in popularity. After several years of declining nicotine use, primarily via combustible cigarettes, recent data suggests a resurgence of nicotine use, primarily via e-cigarettes as well as a marked increase in cannabis use, likely corresponding with legalization efforts. Additionally, there has been an increase in hallucinogen use and the dangers of opioid use have heightened due to the rise of illicit fentanyl being brought in from outside the United States. This lecture will review the most recent Monitoring the Future study and discuss implications of adolescent substance use trends on healthcare providers. | 1.50 credits (1.50 Pharmacology) | $40

The purpose of this workshop is to provide NP’s an update on the treatment of patients with HIV. It will include an overview of the issues that have impacted the uptake and use of PrEP, the newest mediations available for treatment, and a brief discussion on the impact of the end the epidemic initiatives. | 1 credits (0.75 pharmacology) | $30

Alcohol, marijuana, and tobacco are substances most commonly used by adolescents. Substance use in adolescence becomes risky, when does substance use become substance abuse? This presentation will focus on adolescent substance use and abuse. This presentation will also focus on the most commonly abused substances during adolescence, factors that contribute to substance abuse and treatment plans. | 1.50 credits (1.50 pharmacology) | $40

A brief overview of Allergic Asthma and when to apply the newest treatment options. The need to treat aggressively will be a focus as to avoid “remodeling” of the lungs. Using the “Step wise” approach to treatment with a few updates will help the practicing clinician decide what treatments are the best and when to initiate. Time is of the essence with a pulmonary patient and aggressive treatment and management will be the focus of this session. | 1.50 credits (1.50 pharmacology) | $40